Bacterial superantigens, such as staphylococcal enterotoxin B (SEB), can trigger acute pathologic effects in humans. A hydrophobic loop on the surface of SEB and other bacterial superantigens, centered around a conserved leucine (L45) residue, is essential for binding to class II major histocompatibility complex molecules. Single residue changes of wild type SEB, designated Q43P, F44P, or L45R, resulted in nonlethal proteins at a dose equivalent to 30 murine LD 50 of SEB. Relative to SEB, the mutant proteins did not elevate serum concentrations of proinflammatory cytokines in mice and caused minimal proliferation of human lymphocytes. Anti-SEB titers of mice immunized with Q43P, F44P, L45R, or SEB were similar and protected 77% -100% of animals against a lethal SEB challenge. Levels of toxin-specific IgG1, IgG2a, IgG2b, and IgG3 in mice immunized with SEB, Q43P, or F44P were equivalent, but animals immunized with L45R had significantly elevated levels of IgG2a and IgG2b. Vaccines against staphylococcal superantigens should focus on this critical leucine residue.
Laboratories, Chantilly, VA). Unadsorbed sites were blocked for specifically inhibit the in vitro proliferation of human peripheral 1 h at 37ЊC with 5% skim milk solids in PBS. Wells were aspirated, blood mononuclear cells (PBMC) by SEB [29] .
and mouse sera diluted in PBS containing 0.1% Tween 20 plus In an attempt to refine the antigenic structure of a potential 2% skim milk solids were added for 1 h at 37ЊC. The wells were SEB vaccine, we examined the biologic activities of three muthen emptied and washed with PBS containing 0.1% Tween 20,  tant SEB molecules. Single amino acid substitutions were creand sheep anti-mouse IgG conjugated to alkaline phosphatase ated by site-directed mutagenesis and included a proline for In the competition ELISA, equal volumes of mouse anti-SEB located in the N-terminal domain of SEB [30] . One contact serum (1:6400 dilution) and SEB or mutant protein were incubated surface is a pocket of polar side chains interacting with K39
for 1 h at 37ЊC before addition to SEB-coated wells. All other of the DRa subunit, and the second surface is a hydrophobic steps were as described above.
loop. The hydrophobic loop consists of SEB residues 44 -47, 
Materials and Methods

alone. SEB, mutant proteins, and lipopolysaccharide (LPS). Purified
Serum cytokines. Mice were each injected with 5 mg of SEB SEB was purchased from Toxin Technology (Sarasota, FL). Muor mutant protein plus 75 mg of LPS, as described for the lethality tant proteins of SEB (Q43P, F44P, and L45R) were derived by assay. Control groups received either 5 mg of SEB or 75 mg of site-directed mutagenesis of the SEB toxin gene isolated from S.
LPS. Sera were pooled from 4 terminally bled mice/group every aureus 14458 [30]. The modified toxin gene, which resulted in 2 h, up to 12 h after the protein injection, and analyzed for IL-6 single amino acid substitutions, was inserted into plasmid pSE380
and TNF in an ELISA (Genzyme, Boston). IFN-g concentrations and used to transform Escherichia coli DH5a. Gene expression were determined in a bioassay with recombinant IFN-g as a referwas induced with isopropyl-b-D-thio-galactopyranoside (Life ence (BioSources International, Camarillo, CA) [32] . Technologies, Gaithersburg, MD). Mutant proteins were isolated
Immunization. Preimmune sera were collected from mice beby CM-Sepharose ion-exchange chromatography and purified to fore the first antigen injection. Antigen (3 mg/mouse) was comhomogeneity on an affinity column consisting of rabbit anti-SEB bined with alum adjuvant (Pierce Chemical), and each mouse was serum (Toxin Technology). Endotoxin was removed by polymyxin injected ip with 200 mL. One control group received alum only. B (Sigma, St. Louis), and residual endotoxin levels were deterSubsequent injections were given 14 and 28 days later, and sera mined by a limulus amebocyte lysate assay (BioWhittaker, Walkwere collected on days 21 and 35. Anti-SEB titers for each mouse ersville, MD). All protein preparations contained õ1 ng of endoand pooled sera from commonly immunized mice were determined toxin/mg of protein. SEB and mutant proteins were diluted in by an ELISA. Each mouse was challenged with SEB and LPS 10 sterile PBS, pH 7.4, and stored at 050ЊC. SEB concentrations days after the third injection, as described for the lethality assay. were determined by absorbance at 277 nm with an extinction coefNaive, age-matched mice were injected with SEB plus LPS or ficient (E 1% 1 cm ) of 14.4. Mutant protein concentrations were deter-LPS only for comparison. mined in a bicinchoninic acid assay (Pierce Chemical, Rockford,
Passive immunization experiments were done with pooled sera IL) with SEB as a standard. from mice immunized with Q43P, F44P, L45R, or alum alone, as E. coli O55:B5 LPS was obtained from Difco (Detroit), reconstidescribed previously [33] . Naive mice (n Å 5) were used for each tuted in sterile PBS, and stored at 050ЊC. pooled serum. ELISA. Sera from immunized mice were tested for anti-SEB Human PBMC proliferation assays. Proliferation assays with titers in an ELISA. SEB, 5 mg/mL in carbonate buffer, was adhuman PBMC were done as described [34] . Briefly, PBMC were purified by buoyant density gradient centrifugation on Histopaque sorbed overnight at 4ЊC on Immulon II microtiter plates (Dynatech by the mutant proteins with those induced by SEB. Mice injected with SEB plus LPS had significantly elevated serum levels of IFN-g (4-h reading, P õ .001), IL-6 (2-and 4-h proteins. Q43P, F44P, and L45R were very ineffective, un-
Mouse lymphocyte proliferation assays. To test the inhibitory effects of pooled sera from naive or immunized mice on lympholike SEB, at inducing proliferation of human PBMC (figure cyte proliferation, sera were diluted 128-fold in RPMI 1640 me-2). These findings are consistent with the toxicity and serum dium containing 10% fetal calf serum. Lymphocytes from naive cytokine data collected from the mouse experiments. SEB mouse spleens (4 1 10 6 cells/mL) were plated with or without caused substantial lymphocyte proliferation at protein concen-SEB (1 or 0.5 mg/mL) in the presence of pooled sera for 48 h trations as low as 0.1 ng/mL, but the mutant proteins (0.1 -at 37ЊC in microtiter plates. Cells were pulsed with 1 mCi of 1000 ng/mL) elicited no more than 20% of the proliferation ranging from 1 to 10,000 ng/mL.
Lymphocyte proliferation studies were also done with mononuSerologic similarity of mutant proteins and SEB. A single clear cells prepared from the spleens of immunized mice (n Å 2 or 3/immunization group) 10 days after the third antigen injection.
amino acid substitution could disrupt important epitopes and
The proliferation assays were similar to those outlined above, extherefore reduce the effectiveness of a mutant protein as an cept the pooled sera were omitted and cells were incubated with immunogen. The serologic similarities of Q43P, F44P, and 10, 1, or 0.1 mg/mL SEB or 1 or 0.1 mg/mL TSST-1 (Toxin L45R, relative to SEB, were compared in a competition ELISA Technology). A stimulation index, the ratio of [ to SEA, they were statistically different from SEB at 0.16-to 10-mg/mL concentrations (P õ .02). Results from the two lowest competitor concentrations (0.01 and 0.04 mg/mL) of any Results mutant protein versus SEB were not statistically different (P ú .05). The data suggested that the mutant proteins were seroToxicity of SEB mutant proteins. Three mutant proteins of SEB (Q43P, F44P, and L45R), defective in binding to MHC logically similar, but not identical, to SEB and had retained epitopes found on the native toxin. class II molecules [30] (unpublished data), were initially screened for lethal effects in mice, thus identifying those suitAnti-SEB titers of immunized mice. Relative to SEB, the mutant proteins had greatly reduced biologic activities and were able for further investigation as vaccine candidates. Mice survived a 10-mg ip injection of any mutant protein, which is in serologically similar, thus warranting further studies for vac-/ 9d43$$ap29 02-09-98 12:17:11 jinfa UC: J Infect cine potential. To test individual sera for anti-SEB titers in an and IgG2b resulted from immunization with L45R; these titers were statistically different from those induced by SEB (P õ ELISA, mice were immunized three times with antigen plus alum, or alum only, and bled after the second and third injec-.02). We also observed similar sub-isotype patterns in sera collected after the second injection (data not shown). Anti-SEB tions. All animals (n Å 15/group) immunized with SEB, F44P, or L45R seroconverted (absorbance at 405 nm ú0.1 at a 1:200 immunoglobulins were absent in the NMS control. Protection against lethal SEB challenge. Mice received a dilution) after the second immunization (data not shown), whereas 87% of the animals immunized with Q43P seroconlethal combination of SEB plus LPS 10 days after the final immunization to compare the protection afforded by the mutant verted after two injections. All mice given Q43P developed SEB-reactive antibodies after three injections. Pooled sera from proteins versus SEB. There was 77% -100% survival among mice immunized with SEB or any mutant protein, in marked mice immunized with any mutant protein or native toxin had statistically similar ELISA titers (P ú .05) that were still evicontrast (P õ .005) to 0% survival among naive mice or alumonly controls (table 2) . Immunization with Q43P, F44P, or dent at a 1:51,200 dilution (figure 4). There were no detectable SEB antibodies in a 1:200 dilution of pooled sera from preim-L45R resulted in active immunity and statistically the same protective effects as SEB against a lethal SEB challenge. Pasmune or alum-injected mice.
Differences among immunoglobulin sub-isotype titers in the sive immunization with pooled sera (200 mL/mouse) from animals immunized with Q43P, F44P, or L45R completely proimmune mouse sera after three injections of SEB or any mutant protein were determined in an ELISA ( figure 5) . SEB, Q43P, tected against a 2.5-mg SEB challenge, versus no protection among animals given SEB plus sera from alum-injected conand F44P induced statistically similar levels of IgG1, IgG2a, and IgG2b (P ú .05). However, the highest titers of IgG2a trols, suggesting that antibodies neutralized SEB toxicity, and / 9d43$$ap29 02-09-98 12:17:11 jinfa UC: J Infect (21% of alum control stimulation index; P £ .002), Q43P (23% of alum control; P £ .001), or F44P (51% of alum control; P £ .01). Similar patterns of unresponsiveness were also observed for these mononuclear cells incubated with TSST-1, which shares some V b specificities with SEB [5] . The stimulation indices of lymphocytes from animals immunized with SEB, Q43P, or F44P incubated with TSST-1 in vitro were respectively 30% (P £ .02), 33% (P £ .006), and 71% (P õ .05) of the alum control value. Unlike the other immunogens, L45R had a markedly less pronounced effect on lymphocyte proliferation due to SEB (98% of alum control; P ú .05) or TSST-1 (79% of alum control; P ú .05) stimulation in vitro.
Discussion
In this study, we characterized three mutant proteins of SEB that differed from native toxin by single amino acid substitutions in a hydrophobic loop that forms part of the interface protection in immunized mice. Immunization with any of the mutant proteins or native toxin stimulated equivalent anti-SEB titers, but this was not surprising, as Q43P, F44P, and L45R protection following active immunization was not a consewere virtually indistinguishable from SEB in a competitive quence of nonresponsive T cells.
Inhibition of lymphocyte proliferation in vitro. We examined the sera from immunized mice for effects on SEB-induced lymphocyte proliferation, which is commonly associated with superantigenic activity [5, 9, 10, 14, 33] . Sera from mice immunized with SEB or any of the mutant proteins, plus alum, effectively inhibited murine lymphocyte proliferation by SEB relative to sera from naive or alum-injected controls (figure 6; P £ .01). These results suggested that the protective effects from immunization with either SEB or mutant proteins may be linked to preventing lymphocyte proliferation.
Effect of mutant proteins and SEB immunizations on lymphocyte proliferation. In vivo stimulation of T cells with a superantigen causes proliferation of V b -specific lymphocytes and is frequently followed by an immunologically unresponsive state due to anergy or deletion of the reactive cells (or both) [9] . Although the SEB antibodies were protective, as suggested by survival of actively or passively immunized mice against a lethal challenge and inhibition of SEB-induced lymphocyte proliferation in vitro, protection may have partly resulted from unresponsive lymphocytes bearing toxin-specific V b elements. ELISA with SEB antisera. Anti-SEB titers correlated well with from another murine model for SEB, which used D-galactosamine as a potentiating factor, revealed that a monoclonal antiprotection against a lethal SEB challenge. Together, these observations suggest that epitopes necessary for active immunity body against TNF afforded protection against lethality, thus suggesting that TNF is critical in TSS due to SEB [37, 38] . against SEB were retained in the mutant proteins, although the amino acid substitutions that affected DRa binding substan-SEB induces a large increase in serum concentrations of TNF within 2 -4 h after injection into D-galactosamine -sensitized tially reduced toxicity.
The Q43P, F44S, and L45R mutant proteins, unlike SEB, mice [38] . In our animal model, maximum serum concentrations of TNF were present at 6 h after the SEB injection and were not lethal in our mouse model at the tested doses. Reduced toxicity of the mutant proteins paralleled lower serum cytokine 2 h after LPS. These findings are consistent with other murine studies for LPS-potentiated SEB [33] , SEA [14], or TSST-1 levels induced by these mutant proteins in LPS-treated mice. Because the MHC class II molecules of mice do not have lysine [39] . Elevated levels of TNF, persisting for §3 days, are also produced in human mononuclear cells cultured with SEB, SEC, at DRa residue 39, they have lower affinity than the human molecules for staphylococcal superantigens [5] , and the end streptococcal pyrogenic exotoxin A, or TSST-1 [40] . result is that mice are less responsive to these toxins [14, 35] . However, we successfully used LPS to potentiate the biologic Antibody against IFN-g reduces the circulating levels of Besides a lack of lethal effects in mice and diminished cytokine levels relative to SEB, the mutant proteins that we tested IFN-g and severity of SEB intoxication in D-galactosaminetreated mice but does not affect TNF or IL-6 levels, which also did not effectively stimulate human PBMC proliferation. It has been well established that many biologic properties of suggests that IFN-g also contributes to shock in this model [41] . This current study with SEB in the LPS-potentiated mouse the staphylococcal superantigens depend on T cell activation [5, 7, 8, 14, 17 -19, 29] . Specific populations of T cells are model, as well as previous work with SEA or TSST-1 [14, 39] , reveals that IFN-g and TNF are good correlates of lethality. In expanded in diseases of known or suspected superantigen etiology [5] . For example, T cells with V b 2 receptor elements are contrast to findings in mice injected with a staphylococcal superantigen plus LPS or D-galactosamine, mice infected with frequently expanded in the PBMC populations of patients with acute TSS [43] , but this population returns to normal levels in lymphocytic choriomeningitis virus and subsequently injected with SEB plus a neutralizing monoclonal antibody against IFNseveral weeks during convalescence. Expansion among specific V b populations of human T cells suggests that Kawasaki disg died, suggesting that IFN-g is not intimately involved in the lethal effects of these toxins [42] . Obviously, there are ease [23] and rheumatoid arthritis [22] are triggered by superantigens. Proliferation is a relatively late event in superantigen fundamental differences among murine models for bacterial superantigens; such differences lead to different interpretations activation of T cells, preceded by the release of IL-2 and TNF [38] . of the factors (i.e., cytokines) intimately involved in lethality. All of these assays use different potentiating compounds, which
The mutant proteins we studied had single amino acid substitutions in a region of the SEB molecule important for binding further complicates comparisons of data from various laboratories. The development of a reliable, inexpensive animal to a cellular receptor, the MHC class II molecule. Superantigen activity involves binding to the MHC class II molecules of model for bacterial superantigens, minus any exogenous potentiation, would be of interest.
antigen-presenting cells and the V b domain of the T cell receptor [30, 44] . The primary MHC class II binding sites in SEB Of the three cytokines that we measured in mouse sera, the IL-6 concentrations induced by the mutant proteins and LPS consist of a polar pocket, which contains a glutamate and two tyrosines that interact with K39 of DRa, and a hydrophobic were relatively high but comparable to those in LPS controls. IL-6 can evidently protect mice against the lethal effects of loop [44] . Residues 44 -47 of SEB form a hydrophobic interface with the a chain of DR1 [6, 30] . Residue F44 is favorably SEB in a D-galactosamine -induced toxic shock model [37] , and antibodies against IL-6 enhance circulating levels of this situated for MHC class II binding because its side chain is exposed to solvent, as demonstrated by radiographic crystallogcytokine in mice, presumably by the slow release of IL-6 from the antibody -IL-6 complex [41] .
raphy [45] . Substituting arginine for leucine at residue 45 likely / 9d43$$ap29 02-09-98 12:17:11 jinfa UC: J Infect causes steric effects in this loop that markedly diminish binding had comparable anti-SEB titers and were afforded degrees of protection equivalent to that induced by L45R, it is conceivable to the MHC class II molecules [30] . It is noteworthy that this leucine is conserved in all SEs, streptococcal pyrogenic exothat some protective effects seen in mice immunized with SEB, Q43P, or F44P could be attributed partly to an inability of toxin A, and TSST-1 [30, 44] . By changing this specific leucine to glycine in SEA, which is analogous to L45 of SEB, there SEB-reactive lymphocytes to respond to the toxin challenge.
The SEB mutants that we have studied will need further is ú90% reduction in T cell proliferation compared with an equivalent concentration of SEA [46] . evaluation in other animal models to assess their utility as vaccines. Although our mouse model has proven useful for The biologic activities of Q43P, F44P, and L45R were similar in most respects; however, immunization with L45R stimuevaluating the biologic activities and immunogenicities of superantigen vaccine candidates, monkey feeding studies remain lated higher titers of anti-SEB immunoglobulin sub-isotypes IgG2a and IgG2b and did not cause specific lymphocyte anergy the only means of examining the emetic activities of SEs [2] . Emesis and superantigenicity are evidently separate properties and/or deletion. These results suggest that L45R interacts differently with the immune system than does SEB, Q43P, or of SEA and SEB [46, 47] . A mutant protein of SEB (F44S), which does not activate T cells [48] , is emetic at 300 mg when F44P. The immunosuppressive properties of the SEs and TSST-1 are linked to unresponsive T lymphocytes [9, 10, 16 -18] , given to rhesus monkeys by nasogastric intubation [46] . However, a glycine mutation at the analogous F47 site of SEA which suggests that a potential superantigen vaccine, versus native toxin, should induce minimal T cell activation and not produces a molecule that has neither T cell proliferative nor emetic effects [46] . Another SEA mutant, L48G, is emetic at subsequently anergize or delete specific T cell populations involved in humoral responses. In this sense, L45R may be a 500 mg/animal but does not induce proliferation of murine splenocytes. Obviously, residue location and type of substitubetter vaccine candidate than the other two mutant proteins.
Protection in our studies was not due to an inability of lymtion can have a profound effect on the biologic activities of the SEs. phocytes to respond to SEB, as evidenced by the results from mice immunized with L45R and the passive immunization exColonization with S. aureus strains that produce SEs or TSST-1 is widespread among humans, and much of the populaperiments. There were no signs of anergy or specific lymphocyte deletion in L45R-immunized mice relative to alum contion has measurable antibody titers against one or more of these toxins [27] . Because TSS is a serious, potentially lifetrols, plus they had an anti-SEB titer and were protected (100%) against a lethal SEB challenge, unlike the alum controls (0% threatening disease caused by various staphylococcal toxins such as SEB [7, 8] and TSST-1 [9, 10] , an effective vaccine survival). Although mice immunized with SEB, Q43P, or F44P / 9d43$$ap29 02-09-98 12:17:11 jinfa UC: J Infect
